HLS Therapeutics (HLS Therapeutics) Days Sales Outstanding : 55.21 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Days Sales Outstanding?

HLS Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was $9.60 Mil. HLS Therapeutics's Revenue for the three months ended in Dec. 2023 was $15.86 Mil. Hence, HLS Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 55.21.

The historical rank and industry rank for HLS Therapeutics's Days Sales Outstanding or its related term are showing as below:

HLTRF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.77 Med: 66.39 Max: 109.42
Current: 54.79

During the past 13 years, HLS Therapeutics's highest Days Sales Outstanding was 109.42. The lowest was 53.77. And the median was 66.39.

HLTRF's Days Sales Outstanding is ranked better than
67.13% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs HLTRF: 54.79

HLS Therapeutics's Days Sales Outstanding increased from Dec. 2022 (50.06) to Dec. 2023 (55.21).

HLS Therapeutics Days Sales Outstanding Historical Data

The historical data trend for HLS Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Days Sales Outstanding Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

87.01

68.88

62.93

55.45

53.66

HLS Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															50.06	53.98	53.31	57.42	55.21

Competitive Comparison of HLS Therapeutics's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLS Therapeutics's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HLS Therapeutics's Days Sales Outstanding falls into.

HLS Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HLS Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (8.905	+	9.64)	/	2 )	/	63.074	*	365
=	9.2725					/	63.074	*	365
=	53.66

HLS Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (9.556	+	9.64)	/	2 )	/	15.863	*	365 / 4
=	9.598					/	15.863	*	365 / 4
=	55.21

HLS Therapeutics (OTCPK:HLTRF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

HLS Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (HLS Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HLS:Canada

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (HLS Therapeutics) Headlines

From GuruFocus

Automodular Corp. (TSX:AM) - Strong Buy

By Elliot Luchansky, CFA Elliot Luchansky, CFA • 03-21-2013